Gevo, Inc. (GEVO) Stock Analysis

Company Overview

Gevo, Inc. (GEVO) carries a market capitalisation of $405.47M. It is classified in the Specialty Chemicals industry, within the Basic Materials sector. The company reports 151 employees.

Over the past 52 weeks the price has ranged from $1.37 to $2.97. The most recent close on file for GEVO is $1.64, dated September 4, 2026. The close was unchanged from the previous session. The latest close sits 19.71% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $160.58M. That is +849.33% against the prior fiscal year, when revenue was $16.92M. The same year closed with a net loss of $33.84M. The reported profit margin is −119.93%. That is 120 percentage points below the Specialty Chemicals median of 0.08%. Earnings per share on a trailing basis come to −0.91.

Across the 4 fiscal years on file, revenue moves from $1.18M in 2022 to $160.58M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The forward P/E on file is 27.33. The price-to-sales ratio is 2.28. On price-to-sales that is 36.08% above the Specialty Chemicals median of 1.68. The medians here are taken across 71 Specialty Chemicals companies that report the metric.

Beta against the wider market is reported at 1.05. Daily returns over the trailing 10 years annualize to a volatility of 152.05%. The trailing one-year price return is +0.61%. Across 10 years the annualized return works out at −38.95%.

Growth & Income

The record shows no dividend for GEVO.

The strongest complete calendar year on file is 2020 at +83.98%; the weakest is 2018 at −83.39%. Of the 9 complete calendar years on file, 4 finished higher. 2026 is still running; the price is −18.00% year to date.